Equipment & Devices
Equipment & Devices
NAMSA and Lexitas Launch Ophthalmic MedTech Partnership
NAMSA and Lexitas Pharma Services have entered into a strategic partnership aimed at delivering integrated development services for ophthalmic medical devices, positioning themselves as a...
Equipment & Devices
US Speeds Insurance Coverage for Breakthrough Medical Device
A new federal initiative in the United States is set to significantly shorten the timeline for securing insurance access to advanced medical technologies, addressing a...
Equipment & Devices
FDA Flags Nitrosamine Impurity Risk in Combination Products
The U.S. Food and Drug Administration (FDA), through its Center for Devices and Radiological Health (CDRH), has issued a formal communication to manufacturers of CDRH-led...
Equipment & Devices
BVI Virtuoso Receives CE Mark for Dual Eye Surgery System
BVI Medical has secured CE Mark certification under the European Union Medical Device Regulation (EU MDR) for its Virtuoso platform, positioning the system for commercial...
Equipment & Devices
EMA Pilot to Fast-Track Breakthrough Medical Devices in EU
The European Medicines Agency is set to introduce a pilot programme in the second quarter of 2026 aimed at advancing support for breakthrough medical devices...
Equipment & Devices
Predictive Maintenance for Biomedical Equipment Reliability
Implementing advanced predictive maintenance strategies within biomedical equipment systems transforms healthcare technology management from a reactive or preventive approach into a proactive, data-driven discipline. This technological evolution leverages real-time monitoring and analytics to anticipate equipment failures before they occur, ensuring uninterrupted clinical operations and enhanced patient safety.
Equipment & Devices
Equipment as a Service: CAPEX to OPEX Shift in Healthcare
Transitioning from traditional capital expenditure models to operational expenditure through equipment as a service enables healthcare providers to access cutting-edge medical technology while preserving liquid capital and enhancing operational flexibility. This financial evolution addresses the rising costs of medical innovation and the need for scalable, high-performance clinical environments.
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.


















